• C-Mer Medical repurchased 206,000 ordinary shares on July 17, 2026 for treasury, not cancellation.
• Buyback price range HKD 0.95 to HKD 0.96 per share; aggregate consideration HKD 197,600.
• Total shares repurchased or cancelled: 206,000 repurchased; 0 cancelled.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C-Mer Medical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248192), on July 17, 2026, and is solely responsible for the information contained therein.